A detailed history of Salvus Wealth Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Salvus Wealth Management, LLC holds 6,361 shares of JNJ stock, worth $1.05 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
6,361
Previous 6,625 3.98%
Holding current value
$1.05 Million
Previous $1.05 Million 11.35%
% of portfolio
0.65%
Previous 0.73%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$144.38 - $157.78 $38,116 - $41,653
-264 Reduced 3.98%
6,361 $929,000
Q1 2024

Apr 12, 2024

BUY
$155.22 - $162.74 $1,552 - $1,627
10 Added 0.15%
6,625 $1.05 Million
Q4 2023

Jan 08, 2024

SELL
$145.6 - $158.88 $5,241 - $5,719
-36 Reduced 0.54%
6,615 $1.04 Million
Q3 2023

Oct 10, 2023

BUY
$155.75 - $174.48 $16,198 - $18,145
104 Added 1.59%
6,651 $1.04 Million
Q2 2023

Jul 13, 2023

BUY
$154.35 - $166.11 $59,887 - $64,450
388 Added 6.3%
6,547 $1.08 Million
Q1 2023

Apr 11, 2023

BUY
$151.05 - $180.26 $6,495 - $7,751
43 Added 0.7%
6,159 $954,000
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $961 - $1,078
6 Added 0.1%
6,116 $0
Q3 2022

Oct 12, 2022

BUY
$161.33 - $179.52 $40,493 - $45,059
251 Added 4.28%
6,110 $998,000
Q2 2022

Jul 11, 2022

SELL
$168.19 - $186.01 $2,859 - $3,162
-17 Reduced 0.29%
5,859 $1.04 Million
Q1 2022

Apr 11, 2022

BUY
$158.14 - $179.59 $24,827 - $28,195
157 Added 2.75%
5,876 $1.04 Million
Q4 2021

Jan 19, 2022

BUY
$155.93 - $173.01 $24,636 - $27,335
158 Added 2.84%
5,719 $978,000
Q3 2021

Oct 05, 2021

BUY
$161.5 - $179.47 $49,742 - $55,276
308 Added 5.86%
5,561 $898,000
Q2 2021

Jul 09, 2021

BUY
$159.48 - $171.07 $109,243 - $117,182
685 Added 15.0%
5,253 $872,000
Q1 2021

Apr 09, 2021

BUY
$153.07 - $170.48 $108,220 - $120,529
707 Added 18.31%
4,568 $744,000
Q4 2020

Jan 15, 2021

BUY
$137.11 - $157.38 $529,381 - $607,644
3,861 New
3,861 $618,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Salvus Wealth Management, LLC Portfolio

Follow Salvus Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salvus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salvus Wealth Management, LLC with notifications on news.